How the Intended Use of Polygenic Risk Scores Guides the Design and Evaluation of Prediction Studies

AbstractPurpose of ReviewTo explain how the intended use of polygenic risk scores (PRSs) in healthcare guides the design and evaluation of prediction studies.Recent FindingsThe advances in gene discovery in common complex diseases have fueled the interest in the potential of PRSs to predict risks and improve the prevention and early detection of disease. As the predictive ability of a PRS differs between populations and settings, it is important that prediction studies are designed and evaluated with the intended use of the risk scores in mind, but this is rarely done.SummaryThe intended use indicates in whom and how the PRS will be used in healthcare and for what purpose. This intended use dictates what outcome needs to be predicted in which population using which predictors. It also tells which other variables or clinical risk models might be available to improve the prediction. The intended use also provides the necessary context to evaluate whether the predictive ability of the PRS or the risk model that includes PRS is high enough for the score to be potentially useful in healthcare. The intended use should be leading risk prediction research.
Source: Current Epidemiology Reports - Category: Epidemiology Source Type: research
More News: Epidemiology | Genetics | Study